Immunome IMNM
NASDAQ IMNM
$21.95 +0.06 (+0.27%)
As of: Sep 30, 2026 · 12:50 PM EDT

Immunome Inc. (IMNM) Revenue (2023 - 2025)

Updated

Immunome's Revenue was $6.94 million in FY2025, down 23.2% from $9.04 million in FY2024.

Analysis

Immunome Inc. (IMNM) Revenue (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $9.04 million in FY2024 (-35.5%) and $14.02 million in FY2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.02 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.91 Mn
Jun 30, 2024 2.36 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 3.83 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 4.26 Mn
Mar 31, 2023 2.36 Mn
API Access

Immunome Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMNM&period=max&api_key=YOUR_API_KEY